how often do i take retatrutide Starting dose of retatrutide: the complete guide to getting it right VisualAbstract: Retatrutide reduces body weight

Pricing Book Now

doi: 10.1056/NEJMoa1607141 9 ArodaVR

Retatrutide (LY-3437943) is an investigational drug developed by Eli Lilly that acts as a triple hormone receptor agonist : GLP-1 (glucagon-like peptide-1) receptor agonist GIP (glucose-dependent insulinotropic polypeptide) receptor agonist Glucagon receptor agonist - read about why this is so important here This triagonist approach amplifies the metabolic impact seen with GLP-1 and GIP combinations like tirzepatide, while also leveraging glucagons thermogenic and energy-expending properties

Siegner R et al

How to use: Take an appropriate amount and work into rich lather

While the exclusion of weight management treatment may limit reimbursement of GLP-1s, non-obesity/overweight diseases such as diabetes mellitus and certain cardiovascular conditions may be eligible for reimbursement because these indications are not excluded